6Rudnick MR, Jackson S Wexler L, Ludbrook PA,Murphy Mj, Halpern EF, et al. Nephrotoxicity of inonic and nonionic contrast media in 1196 patients: a randomised trial. Kidney lnt 1995,47:254-261.
7Chalmers N Jachson RW Comparison of iodixanol and iohexol in renal impairment. Brit J Radiol 1999,72 : 701-703.
8Grynne BH, Nossen JO, Bolstad B, Borch KW. Main results of the first comparative clinical studies on Visipaque. Acta Radiol 1995,36 : 265-270.
9Kini AA. Sharma SK. Managing the high-risk patient :experience with fenoldopam, a selective dopamine receptor agonist in prevention of radiocontrast nephropathy during percutaneous coronary intervention. RevCardiovasc Med 2001,2(Suppl 1 ):S19-25.
10Diaz-Sandoval I.J Kosowsky BD I.osordo DW Acetylcysteine to prevent angiography-related renal tissue injury (the APART Trial). Am J Cardiol 2002,89:356-358.
